![Avet's Metformin Diabetes Drug Found to Contain Probable Carcinogen, Class Action Claims [UPDATE]](/media/newswire-thumb-metformin.png)
April 3, 2020 According to a class action, generic metformin manufactured by Heritage Pharmaceuticals has been found to contain dangerously high levels of a probable carcinogen.
September 6, 2017 Thirteen new cases have been filed in Pennsylvania federal court as part of a multidistrict litigation accusing numerous pharmaceutical companies of conspiring to fix the prices of generic drugs.
June 6, 2017 Seven more lawsuits have been filed this week as part of a multidistrict litigation that accuses the pharmaceutical companies of conspiring to fix generic drug prices.
April 5, 2017 Aurobindo Pharma USA, Inc., Citron Pharma LLC, Teva Pharmaceuticals USA, Inc., Heritage Pharmaceuticals, Inc. and two Heritage executives are the defendants in a lawsuit.
